Lara Dunn

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri et al. · The Lancet Oncology · 2021 · 617 citations

Medicine, Oncology, Radiation Oncology +8

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2020 · 394 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Suzanne L. Topalian, Shailender Bhatia, Asim Amin et al. · Journal of Clinical Oncology · 2020 · 271 citations · Full text

Medicine, Immunology, Oncology +17

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques

Jonathan E. Leeman, Jingao Li, Xin Pei et al. · JAMA Oncology · 2017 · 250 citations · Full text

Medicine, Oncology, Radiation Oncology +14